Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AntiSeptic: Resistance Testing for Wound Treatment
NCT04172363Phase 3Withdrawn
- Sponsor
- RWTH Aachen University
- Start
- Jul 2020
- Primary completion
- May 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of octenidine dihydrochloride + phenoxyethanol, polihexanide in pressure ulcer, Chronic wound, acute wound, sponsored by RWTH Aachen University. Planned start Jul 2020; status: withdrawn.
02
Drugs
octenidine dihydrochloride + phenoxyethanolpolihexanide
03
Conditions
pressure ulcerChronic woundacute wound
Beyond the preview
Go deeper on NCT04172363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04172363.